XML 51 R39.htm IDEA: XBRL DOCUMENT v3.23.3
Long-Term Investments (Details) - Schedule of Ownership Percentages of Each Investee
9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Jul. 01, 2022
Braingenesis Biotechnology Co., Ltd. [Member]      
Long-Term Investments (Details) - Schedule of Ownership Percentages of Each Investee [Line Items]      
Ownership percentage 0.22% 0.22%  
Accounting treatments Cost Method    
Genepharm Biotech Corporation [Member]      
Long-Term Investments (Details) - Schedule of Ownership Percentages of Each Investee [Line Items]      
Ownership percentage 0.92% 0.92%  
Accounting treatments Cost Method    
BioHopeKing Corporation [Member]      
Long-Term Investments (Details) - Schedule of Ownership Percentages of Each Investee [Line Items]      
Ownership percentage 8.03% 8.03%  
Accounting treatments Cost Method    
BioFirst Corporation [Member]      
Long-Term Investments (Details) - Schedule of Ownership Percentages of Each Investee [Line Items]      
Ownership percentage 23.53% 21.77%  
Accounting treatments Equity Method    
Rgene Corporation [Member]      
Long-Term Investments (Details) - Schedule of Ownership Percentages of Each Investee [Line Items]      
Ownership percentage 28.85% 28.85% 12.80%
Accounting treatments Equity Method